Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,217.00% | -171.97% | -110.25% | -106.49% | -81.99% |
| Total Depreciation and Amortization | 16.05% | 8.44% | 2.58% | -7.40% | 0.71% |
| Total Amortization of Deferred Charges | 5.29% | -1.62% | -9.26% | -12.56% | -15.65% |
| Total Other Non-Cash Items | 1,187.83% | 7.44% | 45.35% | 83.74% | 10,499.72% |
| Change in Net Operating Assets | -10.56% | 48.15% | 61.99% | 89.03% | 8.21% |
| Cash from Operations | -49.97% | -20.98% | -7.55% | -17.50% | -31.91% |
| Capital Expenditure | -30.84% | -71.76% | -56.16% | -74.96% | -56.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 101.48% | -- | -- | -447.47% | -447.47% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.82% | 134.83% | 68.59% | -1,260.40% | -- |
| Cash from Investing | 83.63% | -177.27% | -314.97% | -383.59% | -536.80% |
| Total Debt Issued | -78.50% | -67.57% | 194.67% | 205.93% | 1,657.81% |
| Total Debt Repaid | 39.82% | -65.29% | -69.20% | 11.26% | -21.01% |
| Issuance of Common Stock | -86.85% | -88.59% | 48.20% | -16.85% | -0.44% |
| Repurchase of Common Stock | 97.00% | 57.29% | 80.07% | 80.88% | -14.02% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.12% | -4,724.92% | -51.33% | -61.31% | -61.31% |
| Cash from Financing | -106.16% | -129.32% | 203.45% | 174.24% | 174.76% |
| Foreign Exchange rate Adjustments | 675.81% | 250.57% | -266.21% | 24.99% | -250.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.85% | -223.99% | 83.34% | 75.41% | 31.90% |